Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
OBSTETRICS/GYNECOLOGY	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
undifferentiated	O
endometrial	O
sarcoma	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
total	O
abdominal	O
hysterectomy	O
and	O
bilateral	O
salpingo-oopherectomy	O
History	O
of	O
Present	O
Illness:	O
___	O
y	O
G4P4004	O
presents	O
with	O
undifferentiated	O
endometrial	O
sarcoma.	O
She	O
began	O
having	O
vaginal	O
bleeding	O
on	O
___,	O
light	O
at	O
first	O
and	O
then	O
extremely	O
heavy;	O
went	O
to	O
urgent	O
care	O
at	O
___	O
and	O
then	O
___	O
for	O
eval;	O
and	O
then	O
saw	O
her	O
gynecologist	O
Dr.	O
___	O
on	O
___	O
when	O
she	O
had	O
an	O
ultrasound	O
and	O
EMB.	O
Now	O
bleeding	O
has	O
lessened,	O
would	O
soak	O
about	O
2	O
pads	O
per	O
day,	O
but	O
changes	O
more	O
frequently	O
for	O
comfort.	O
Never	O
had	O
PMB	O
prior	O
to	O
this	O
episode.	O
Reports	O
headache,	O
and	O
left	O
leg	O
swelling	O
3	O
weeks	O
ago	O
that	O
has	O
since	O
resolved.	O
She	O
denies	O
any	O
early	O
satiety,	O
unintentional	O
weight	B-Weight_loss
changes,	B-Weight_loss
nausea/vomiting,	O
SOB/CP,	O
increased	O
abdominal	O
girth,	O
abdominal	O
or	O
pelvic	O
pain,	O
or	O
change	O
in	O
her	O
bowel	O
or	O
bladder	O
habits.	O
Past	O
Medical	O
History:	O
Obstetrical	O
History:	O
-	O
G4P4004	O
-	O
SVD	O
x	O
4	O
Gynecologic	O
History:	O
-	O
LMP	O
at	O
age	O
___	O
-	O
Denies	O
history	O
of	O
abnormal	O
uterine	O
bleeding	O
or	O
dysmenorrhea	O
-	O
Denies	O
history	O
of	O
abnormal	O
Pap	O
tests	O
-	O
Denies	O
history	O
of	O
pelvic	O
infections	O
of	O
sexually	O
transmitted	O
infections	O
-	O
Reports	O
history	O
of	O
fibroids	O
Past	O
Medical	O
History:	O
-	O
Meningioma	O
s/p	O
craniotomy	O
___,	O
radiation	O
___,	O
no	O
seizures,	B-Seizures
no	O
residual	O
deficits,	O
surveillance	O
WNL	O
-	O
Hypertension	O
-	O
Hypercholesterolemia	O
Health	O
Maintenance:	O
-Mammogram:	O
___	O
-Colonoscopy:	O
no	O
-Bone	O
Mineral	O
Density:	O
___	O
Past	O
Surgical	O
History:	O
-Craniotomy	O
___	O
for	O
meningioma	O
-Varicose	O
vein	O
surgery	O
Social	O
History:	O
___	O
Family	O
History:	O
Denies	O
a	O
known	O
family	O
history	O
of	O
breast,	O
ovarian,	O
uterine,	O
cervical,	O
or	O
colon	O
malignancy	O
Physical	O
Exam:	O
Vitals:	O
stable	O
within	O
normal	O
limits	O
General:	O
NAD,	O
comfortable	O
appearing.	O
Neuro:	O
AxO	B-Delirium
x	O
3,	O
affect	O
appropriate.	O
HEENT:	O
Normocephalic,	O
atraumatic.	O
Sclerae	O
anicteric.	O
Cardiovascular:	O
RRR,	O
no	O
rubs/murmurs/gallops.	O
Pulmonary:	O
normal	O
rate	O
and	O
work	O
of	O
breathing,	O
Lungs	O
CTAB	O
Abdomen:	O
Normoactive	O
bowel	O
sounds.	O
Soft,	O
minimally	O
tender	O
to	O
palpation,	O
mildly-distended.	O
No	O
rebound/guarding.	O
Incisions	O
clean,	O
dry,	O
and	O
intact	O
without	O
erythema	O
or	O
exudate	O
GU:	O
no	O
pad	O
in	O
place.	O
MSK:	O
Lower	O
extremities	O
without	O
edema,	O
erythema,	O
or	O
TTP.	O
Pertinent	O
Results:	O
ADMISSION/PRE-OP	O
LABS	O
___	O
06:10AM	O
BLOOD	O
WBC-4.4	O
RBC-4.10	O
Hgb-12.1	O
Hct-36.7	O
MCV-90	O
MCH-29.5	O
MCHC-33.0	O
RDW-12.5	O
RDWSD-40.9	O
Plt	O
___	O
___	O
06:10AM	O
BLOOD	O
Glucose-112*	O
UreaN-9	O
Creat-0.7	O
Na-144	O
K-3.6	O
Cl-106	O
HCO3-28	O
AnGap-10	O
___	O
06:10AM	O
BLOOD	O
Calcium-9.5	O
Phos-3.5	O
Mg-2.0	O
Brief	O
Hospital	O
Course:	O
Ms.	O
___	O
is	O
a	O
___	O
year	O
old	O
woman	O
who	O
was	O
admitted	O
to	O
the	O
gynecologic	O
oncology	O
service	O
after	O
undergoing	O
total	O
abdominal	O
hysterectomy	O
and	O
bilateral	O
salpingo-oopherectomy	O
for	O
undifferentiated	O
uterine	O
sarcoma.	O
Please	O
see	O
the	O
operative	O
report	O
for	O
full	O
details.	O
Her	O
post-operative	O
course	O
is	O
detailed	O
as	O
follows.	O
Immediately	O
postoperatively,	O
her	O
pain	O
was	O
controlled	O
with	O
a	O
thoracic	O
epidural	O
catheter.	O
Her	O
diet	O
was	O
advanced	O
without	O
difficulty	O
and	O
she	O
was	O
transitioned	O
to	O
oral	O
ibuprofen,	O
acetaminophen,	O
and	O
oxycodone.	O
On	O
post-operative	O
day	O
#3,	O
her	O
urine	O
output	O
was	O
adequate	O
so	O
her	O
Foley	O
catheter	O
was	O
removed	O
and	O
she	O
voided	O
spontaneously.	O
By	O
post-operative	O
day	O
4,	O
she	O
was	O
tolerating	O
a	O
regular	O
diet,	O
voiding	O
spontaneously,	O
ambulating	B-Independently_mobile
independently,	B-Independently_mobile
and	O
pain	O
was	O
controlled	O
with	O
oral	O
medications.	O
She	O
was	O
then	O
discharged	O
home	O
in	O
stable	O
condition	O
with	O
outpatient	O
follow-up	O
scheduled.	O
She	O
will	O
remain	O
on	O
lovenox	O
for	O
DVT	O
prophylaxis	O
for	O
28	O
days	O
post-operatively.	O
Medications	O
on	O
Admission:	O
1.	O
amLODIPine	O
10	O
mg	O
PO	O
HS	O
2.	O
Pravastatin	O
40	O
mg	O
PO	O
QPM	O
Discharge	O
Medications:	O
1.	O
Acetaminophen	O
___	O
mg	O
PO	O
Q6H:PRN	O
Pain	O
-	O
Mild	O
Reason	O
for	O
PRN	O
duplicate	O
override:	O
Alternating	O
agents	O
for	O
similar	O
severity	O
RX	O
*acetaminophen	O
500	O
mg	O
___	O
capsule(s)	O
by	O
mouth	O
every	O
six	O
hours	O
Disp	O
#*60	O
Capsule	O
Refills:*1	O
2.	O
Enoxaparin	O
Sodium	O
40	O
mg	O
SC	O
DAILY	O
RX	O
*enoxaparin	O
40	O
mg/0.4	O
mL	O
40	O
mg	O
subcutaneous	O
injection	O
daily	O
Disp	O
#*24	O
Syringe	O
Refills:*0	O
3.	O
Ibuprofen	O
400	O
mg	O
PO	O
Q8H:PRN	O
Pain	O
-	O
Mild	O
RX	O
*ibuprofen	O
400	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
every	O
8	O
hours	O
Disp	O
#*60	O
Tablet	O
Refills:*1	O
4.	O
OxyCODONE	O
(Immediate	O
Release)	O
5	O
mg	O
PO	O
Q4H:PRN	O
Pain	O
-	O
Severe	O
RX	O
*oxycodone	O
5	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
every	O
4	O
horus	O
Disp	O
#*10	O
Tablet	O
Refills:*0	O
5.	O
amLODIPine	O
10	O
mg	O
PO	O
HS	O
6.	O
Pravastatin	O
40	O
mg	O
PO	O
QPM	O
Discharge	O
Disposition:	O
Home	B-Has_carers
With	B-Has_carers
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
undifferentiated	O
uterine	O
sarcoma	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
.	O
You	O
were	O
admitted	O
to	O
the	O
gynecologic	O
oncology	O
service	O
after	O
undergoing	O
the	O
procedures	O
listed	O
below.	O
You	O
have	O
recovered	O
well	O
after	O
your	O
operation,	O
and	O
the	O
team	O
feels	O
that	O
you	O
are	O
safe	O
to	O
be	O
discharged	O
home.	O
Please	O
follow	O
these	O
instructions:	O
.	O
*	O
Take	O
your	O
medications	O
as	O
prescribed.	O
We	O
recommend	O
you	O
take	O
non-narcotics	O
(i.e.	O
Tylenol,	O
ibuprofen)	O
regularly	O
for	O
the	O
first	O
few	O
days	O
post-operatively,	O
and	O
use	O
the	O
narcotic	O
as	O
needed.	O
As	O
you	O
start	O
to	O
feel	O
better	O
and	O
need	O
less	O
medication,	O
you	O
should	O
decrease/stop	O
the	O
narcotic	O
first.	O
*	O
Take	O
a	O
stool	O
softener	O
to	O
prevent	O
constipation.	B-Constipation
You	O
were	O
prescribed	O
Colace.	O
If	O
you	O
continue	O
to	O
feel	O
constipated	B-Constipation
and	O
have	O
not	O
had	O
a	O
bowel	O
movement	O
within	O
48hrs	O
of	O
leaving	O
the	O
hospital	O
you	O
can	O
take	O
a	O
gentle	O
laxative	O
such	O
as	O
milk	O
of	O
magnesium.	O
*	O
Do	O
not	O
drive	O
while	O
taking	O
narcotics.	O
*	O
Do	O
not	O
combine	O
narcotic	O
and	O
sedative	O
medications	O
or	O
alcohol.	O
*	O
Do	O
not	O
take	O
more	O
than	O
4000mg	O
acetaminophen	O
(tylenol)	O
in	O
24	O
hrs.	O
*	O
No	O
strenuous	O
activity	O
until	O
your	O
post-op	O
appointment.	O
*	O
Nothing	O
in	O
the	O
vagina	O
(no	O
tampons,	O
no	O
douching,	O
no	O
sex)	O
for	O
12	O
weeks.	O
*	O
No	O
heavy	O
lifting	O
of	O
objects	O
>10	O
lbs	O
for	O
6	O
weeks.	O
*	O
You	O
may	O
eat	O
a	O
regular	O
diet.	O
*	O
It	O
is	O
safe	O
to	O
walk	O
up	O
stairs.	O
.	O
Incision	O
care:	O
*	O
You	O
may	O
shower	O
and	O
allow	O
soapy	O
water	O
to	O
run	O
over	O
incision;	O
no	O
scrubbing	O
of	O
incision.	O
No	O
bath	O
tubs	O
for	O
6	O
weeks.	O
*	O
You	O
should	O
remove	O
your	O
port	O
site	O
dressings	O
___	O
days	O
after	O
your	O
surgery,	O
if	O
they	O
have	O
not	O
already	O
been	O
removed	O
in	O
the	O
hospital.	O
Leave	O
your	O
steri-strips	O
on.	O
If	O
they	O
are	O
still	O
on	O
after	O
___	O
days	O
from	O
surgery,	O
you	O
may	O
remove	O
them.	O
*	O
Since	O
you	O
have	O
staples,	O
you	O
will	O
have	O
an	O
appointment	O
for	O
them	O
to	O
be	O
removed	O
.	O
Lovenox	O
injections:	O
*	O
Patients	O
having	O
surgery	O
for	O
cancer	O
have	O
risk	O
of	O
developing	O
blood	O
clots	O
after	O
surgery.	O
This	O
risk	O
is	O
highest	O
in	O
the	O
first	O
four	O
weeks	O
after	O
surgery.	O
You	O
will	O
be	O
discharged	O
with	O
a	O
daily	O
Lovenox	O
(blood	O
thinning)	O
medication.	O
This	O
is	O
a	O
preventive	O
dose	O
of	O
medication	O
to	O
decrease	O
your	O
risk	O
of	O
a	O
forming	O
a	O
blood	O
clot.	O
A	O
visiting	O
nurse	O
___	O
assist	O
you	O
in	O
administering	O
these	O
injections.	O
.	O
To	O
reach	O
medical	O
records	O
to	O
get	O
the	O
records	O
from	O
this	O
hospitalization	O
sent	O
to	O
your	O
doctor	O
at	O
home,	O
call	O
___.	O
.	O
Best	O
wishes,	O
Your	O
___	O
GYN/Oncology	O
Team	O
Followup	O
Instructions:	O
___	O

